14:51 IST
BSE
Results Update
Alembic Pharmaceuticals Results Update
Alembic Pharmaceuticals reported Q1 FY27 revenue of Rs. 2,150 Crore, a 26% YoY increase. Net profit rose 12% to Rs. 173 Crore during the period.
Alembic Pharmaceuticals Ltd
- Share price
- ₹832.30
- Market cap
- ₹16,360 Cr
- Revenue (annual)
- ₹7,345 Cr
- Net profit (annual)
- ₹674.8 Cr
- P/E (TTM)
- 23.6×Sector 47.4×
- Promoter holding
- 69.87%+0.13% QoQ
- FII holding
- 4.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Management Change 13Debt & Borrowing 9Merger & Restructuring 8Regulatory Approval 7Earnings Call 5Business Update 5Financial Results 3Results Update 2Other Announcement 2Credit Rating 2Board Meeting Date 2Annual General Meeting 2Legal & Regulatory 1Dividend 1Annual Report 1
Time
2 announcements with these filters
14:20 IST
NSE
Results Update
Alembic Pharmaceuticals Results Update
Alembic Pharmaceuticals reported a 26% revenue increase to ₹2,150 Crore for Q1 FY27. Profit After Tax grew 12% to ₹173 Crore, driven by strong US growth.
- Value
- ₹2,150 Cr